GFPT2/GFAT2 and AMDHD2 act in tandem to control the hexosamine pathway
The hexosamine biosynthetic pathway (HBP) produces the essential metabolite UDP-GlcNAc and plays a key role in metabolism, health, and aging. The HBP is controlled by its rate-limiting enzyme glutamine fructose-6-phosphate amidotransferase (GFPT/GFAT) that is directly inhibited by UDP-GlcNAc in a fe...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
eLife Sciences Publications Ltd
2022-03-01
|
| シリーズ: | eLife |
| 主題: | |
| オンライン・アクセス: | https://elifesciences.org/articles/69223 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
